Large-scale testing (Phase 3)Study completedNCT01032395
What this trial is testing
Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
Who this might be right for
H1N1 Influenza VirusChronic Pulmonary DiseaseChronic Heart Disease+1 more
Chiltern Pesquisa Clinica Ltda 342